IFI-M · USK Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-02543 // MULTI-AXIS · IFI-M

USK Tri-Axis Dominant-Primary Series IV-PR

Solanum lycopersicum

Tomato

Tier IVUSK Tri-Axis Dominant-Primary Series

Target Trait

2.38×

fold-change

Umami-dominant tri-axis S+K modulated fold-change

Technical Specifications

SKU

SS-F-M3-02543

Genomic Edits

11

GC Content

48.9%

Construct Length

6,145 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

mGluR1 + TAS1R2/TAS1R3 + CaSR

IFI Score

238

Pathway Edits

  • mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
  • TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
  • CaSR pathway primary gene cluster for kokumi (IFI-K) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent USK pathway operation
  • Cross-pathway regulatory circuit for umami-dominant USK triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: mGluR1, TAS1R2/TAS1R3, and CaSR pathways simultaneously engineeredUmami-dominant tri-axis expression strategy (USK) with cross-pathway flux managementPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier IV USK triple-axis construct for advanced multi-modal sensory architecture combining umami, sweet, and kokumi axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$3999 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?